Xcout Intel
Feldan Therapeutics
Feldan Therapeutics is a clinical-stage biopharmaceutical company based in Quebec City, Canada. The company specializes in developing innovative intracellular delivery technologies and therapeutics where they matter most.
Subscribe to see Feldan Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Feldan Therapeutics at a glance
Feldan Therapeutics is a biotechnology company headquartered in Canada. It has raised at least $18.5M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $12.5M in September 2018. Xcout tracks 12 named people at Feldan Therapeutics, including Vincent Ménard (Chief Financial Officer (CFO)).
Feldan Therapeutics leadership
- Vincent MénardChief Financial Officer (CFO)
- David J. MazzoChairman
- François-Thomas Michaud, PhD, EngChief Executive Officer & Co-Founder
- Catherine LippéVP - Clinical Development
- David GuayVP - INNOVATION & TECHNOLOGY
- Meriem BenchabaneVP - STRATEGIC DEVELOPMENT & OPERATIONS
6 more named people on record for Feldan Therapeutics, with roles, board committees and tenure — see the full roster →
Feldan Therapeutics funding rounds
At least $18.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $12.5M | 4 named | |
| Seed | $6M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Feldan Therapeutics competitors
A few of Feldan Therapeutics's closest competitors — see the full list of competitors and alternatives →
Defence Therapeutics is a publicly traded Canadian biotechnology company headquartered in Montreal, Quebec. It is a precision intracellular drug-delivery company focused on unlocking the full potential of cancer biologics.
Thryv Therapeutics Inc., formerly known as LQT Therapeutics Inc., is a privately owned clinical-stage biotechnology company based in Montreal, Quebec, Canada. The company pioneers targeted therapeutic treatments addressing serious medical conditions. Operating out of its downtown Montreal headquarters, the firm manages dedicated research and development programs.
DTx Pharma, Inc. is a privately held biotechnology company based in San Diego, California, that addresses the challenges associated with delivering RNA-based therapeutics.
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Fulgent Pharma LLC is a clinical-stage pharmaceutical company that develops innovative cancer therapeutics using a patented nanoencapsulation technology. The company focuses on improving existing chemotherapy drugs and creating new drug candidates to treat various cancers while reducing toxicity and enhancing drug delivery and safety.
Get Feldan Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Feldan Therapeutics in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access